Macular degeneration trials in Argentina

In Argentina 6 Also abroad 220

6 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Where
CABA, Rosario
Age
50 years and over
People
272 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07441642 · EU 2025-523704-77-00
No phaseNot yet taking people in Argentina
Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)
Where
Buenos Aires
Age
50 years and over
People
1,000 worldwide
Run by
University of Wisconsin, Madison
See details and how to joinNCT06924021
Phase 3Taking people
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Where
Capital Federal, Ciudad Autonoma Buenos Aires, Rosario
Age
50 years and over
People
1,000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT03683251 · EU 2023-507131-38-00
Phase 3Active, not recruiting
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Where
Buenos Aires, Córdoba, Mendoza, Rosario, Salta
Age
50 years and over
People
480 worldwide
Run by
4D Molecular Therapeutics
See details and how to joinNCT07064759
Phase 2/3Taking people
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Where
Buenos Aires, Cdad. Autónoma de Buenos Aires, Córdoba, Mendoza, Rosario, Salta
Age
50 years and over
People
960 worldwide
Run by
EyeBiotech Ltd.
See details and how to joinNCT07440225
Phase 2Not yet taking people in Argentina
A Study in Adults With Geographic Atrophy
Where
Buenos Aires, Ciudad Autonoma Buenos Aires, Córdoba, Mendoza, Quilmes, Rosario, Salta
Age
60 years and over
People
300 worldwide
Run by
Sitala Bio LTD
See details and how to joinNCT07606365 · EU 2026-525738-40-00